Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPersonalized MedicinePivotal Practice Views with the Oncology BrothersPodcastsSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Myeloma
  • Chronic Lymphocytic Leukemia
  • Gynecologic Cancers
  • Genomic Testing
  • Melanoma
  • Genitourinary Cancers
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Meeting Spolight: 2021 International Kidney Cancer Symposium

home / publications / supplement / meeting-spolight-2021-international-kidney-cancer-symposium

Neoadjuvant Therapy Is a Significant Focus of Ongoing Research for RCC

Neoadjuvant Therapy Is a Significant Focus of Ongoing Research for RCC

Will Pizii
December 21st 2021
Article

Cabozantinib/Nivolumab Combination Demonstrates Efficacy in nccRCC

Cabozantinib/Nivolumab Combination Demonstrates Efficacy in nccRCC

Will Pizii
December 21st 2021
Article

Extended CLEAR Trial Follow- Up Shows Maintained Efficacy of Lenvatinib/Sunitinib in RCC

Extended CLEAR Trial Follow- Up Shows Maintained Efficacy of Lenvatinib/Sunitinib in RCC

Lisa Astor
December 21st 2021
Article

Nivolumab/Cabozantinib Improves Survival in Advanced RCC, Even With Bone Metastasis

Nivolumab/Cabozantinib Improves Survival in Advanced RCC, Even With Bone Metastasis

Lisa Astor
December 21st 2021
ArticleClinical Articles

Managing Adverse Reactions in Patients With RCC Treated With Lenvatinib/Pembrolizumab

Managing Adverse Reactions in Patients With RCC Treated With Lenvatinib/Pembrolizumab

Lisa Astor
December 21st 2021
ArticleClinical Articles

Proactive management of treatment-emergent adverse events, including treatment interruption, may be crucial for patients with renal cell carcinoma receiving lenvatinib in combination with pembrolizumab, according to the CLEAR study investigators.


Frontline Immunotherapy-Based Regimens Shift Survival Outcomes for Patients With Metastatic RCC

Frontline Immunotherapy-Based Regimens Shift Survival Outcomes for Patients With Metastatic RCC

Sara Karlovitch
December 20th 2021
ArticleClinical Articles

Despite advanced in the field of renal cell carcinoma, most patients still die of the disease and more options and new targets are needed, says Moshe C. Ornstein, MD, MA.


With Nivolumab/Ipilimumab, Advanced RCC Survival Approaches 5 Years

With Nivolumab/Ipilimumab, Advanced RCC Survival Approaches 5 Years

Sara Karlovitch
December 20th 2021
ArticleClinical Articles
About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Editorial Board
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.